EXOME: Biotech • Healthcare • Life Sciences

National
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More

1.
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs | San Diego
2.
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More | National
3.
Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed | Boston
4.
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M | Boston
5.
Corza Health Emerges Led by Former NuVasive, GreatCall Executives | San Diego
6.
As Exact Sciences’ Sales Surge, CEO Reflects on 10-Year Turnaround | Wisconsin

Gene Therapy Boom, Cracking Alzheimer’s: What’s Hot on May 21

$35M

Sherlock Biosciences

Genentech’s Lieu Jumps to NGM Bio for Chief Medical Officer Post

Ex-Bayer Exec Adrian Percy Named Finistere Chief Technology Officer

Pfizer Bolsters Gene Therapy Position with $51M Vivet Deal
Ben Fidler | New York
Flagship Reloads With $824M For Latest Growth Capital Fund
Ben Fidler | Boston
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
Ben Fidler | Boston
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival
Frank Vinluan | San Diego
Dermira Shares Soar After Eczema Drug Hits Goal of Mid-Stage Study
Frank Vinluan | San Francisco
Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments
Sarah de Crescenzo | San Diego
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More
Frank Vinluan | National
WI Watchlist: Foxconn Fund, UW Accelerator, MSOE A.I. Hall & More
Jeff Engel | Wisconsin
Gene Therapy Boom, Cracking Alzheimer’s: What’s Hot on May 21
Ashley Gentile | Boston

Read More Posts ›

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Protecting Your Life Science Manufacturing Operations: Monitoring Solutions
Implementing a reliable and auditable monitoring program for life science samples, assets & equipment
XiltriX

Sponsored · Whitepaper
Monitoring Solutions for Pharma-CRO/CMO Partnerships to Maintain Quality & Timelines
Implementing electronic solutions for risk mitigation
XiltriX

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Facing an Uncertain Future
Xconomy

Tweets from https://twitter.com/Xconomy/lists/lifesci